Cancer Home > Irinitican

Were you looking for information about Irinotecan? Irinitican is a common misspelling of irinotecan.
By blocking certain enzymes in the body, irinotecan (Camptosar®) can help slow down the progression of colon or rectal cancer in adults. It is given intravenously (by IV) every one to three weeks by a healthcare provider.
Although most people tolerate this medicine well, side effects are possible and may include diarrhea, nausea, and vomiting. You may not be able to use this drug if you have certain medical conditions, such as heart disease, bone marrow problems, or a bowel obstruction.
(For more information on this medicine, click Irinotecan. This full-length article offers a complete overview of this medication, including how it works, specific uses, and general dosing guidelines. You can also click any of the links in the box to the right for more specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.